Northern Trust’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-161,976
Closed -$2.05M 4334
2014
Q3
$2.05M Buy
161,976
+13,765
+9% +$206K ﹤0.01% 3088
2014
Q2
$2.52M Sell
148,211
-15,721
-10% -$234K ﹤0.01% 2944
2014
Q1
$2.21M Sell
163,932
-19,003
-10% -$249K ﹤0.01% 3073
2013
Q4
$2.34M Buy
182,935
+6,031
+3% +$63.3K ﹤0.01% 3053
2013
Q3
$1.6M Buy
176,904
+60,156
+52% +$499K ﹤0.01% 3188
2013
Q2
$841K Buy
+116,748
New +$857K ﹤0.01% 3316

Northern Trust's DRTX Position: Q4 2014 in Review

Northern Trust sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 161,976 shares — an estimated $2.05M sold.

Northern Trust first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $2.52M in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • Northern Trust reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Northern Trust sold 161,976 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $2.05M.
  • Northern Trust first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • Northern Trust's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $2.52M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Northern Trust's 13F filing for Q4 2014, filed 12 Feb 2015.